Very true and it's why the word "anticipated" is used to estimate when topline results might come out. The CEO has no control over when the statistics vendor gets the unlocked data and runs the programs for comparison data.
Brilacidin has never failed a clinical trial, and while it's pins and needles time as we wait, I'm personally feeling confident given the drug's performance in other clinical trials and in vitro at the Regional Bio Labs.
Would love to see it all released next week though.
News 
Market Data 
Discover 
AI
